Cancer treatment induced metabolic syndrome: improving outcome with lifestyle

Publication date: Available online 3 November 2016
Source:Critical Reviews in Oncology/Hematology
Author(s): N.L. Westerink, J. Nuver, Lefrandt, A.H. Vrieling, J.A. Gietema, A.M.E. Walenkamp
Increasing numbers of long-term cancer survivors face important treatment related adverse effects. Cancer treatment induced metabolic syndrome (CTIMetS) is an especially prevalent and harmful condition. The aetiology of CTIMetS likely differs from metabolic syndrome in the general population, but effective treatment and prevention methods are probably similar. In this review, we summarize the potential mechanisms leading to the development of CTIMetS after various types of cancer treatment. Furthermore, we propose a safe and accessible method to treat or prevent CTIMetS through lifestyle change. In particular, we suggest that a lifestyle intervention and optimization of energy balance can prevent or mitigate the development of CTIMetS, which may contribute to optimal survivorship care.



from Cancer via ola Kala on Inoreader http://ift.tt/2f7bPRK
via IFTTT